Overview on the efficacy and safety of gadobutrol: An MRI contrast agent for the CNS, body and vessels

Juan E. Gutierrez, Sara Koenig, Josy Breuer

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Contrast-enhanced MRI has become a mainstay of clinical imaging with unlimited applications. However, a limitation of conventional contrast agents in MRI is the insufficient signal-to-noise ratios due to relaxivity. Gadobutrol (1.0 mmol/ml), an extracellular macrocyclic contrast agent of high stability, is indicated for contrast-enhanced MRI of adults, adolescents and children 2 years of age and older. Gadobutrol offers increased T 1 relaxivity, which improves MR image quality and clinical use of the technique.

Original languageEnglish (US)
Pages (from-to)25-40
Number of pages16
JournalImaging in Medicine
Volume4
Issue number1
DOIs
StatePublished - Feb 2012

Fingerprint

Contrast Media
Safety
Signal-To-Noise Ratio
gadobutrol

Keywords

  • CNS
  • contrast-enhanced MRA
  • contrast-enhanced MRI
  • Gadavist™
  • gadobutrol
  • gadolinium-based contrast agent
  • Gadovist™
  • kidney
  • liver

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Overview on the efficacy and safety of gadobutrol : An MRI contrast agent for the CNS, body and vessels. / Gutierrez, Juan E.; Koenig, Sara; Breuer, Josy.

In: Imaging in Medicine, Vol. 4, No. 1, 02.2012, p. 25-40.

Research output: Contribution to journalArticle

Gutierrez, Juan E. ; Koenig, Sara ; Breuer, Josy. / Overview on the efficacy and safety of gadobutrol : An MRI contrast agent for the CNS, body and vessels. In: Imaging in Medicine. 2012 ; Vol. 4, No. 1. pp. 25-40.
@article{6a7d9fa3eb0240a183bb47c583e66d51,
title = "Overview on the efficacy and safety of gadobutrol: An MRI contrast agent for the CNS, body and vessels",
abstract = "Contrast-enhanced MRI has become a mainstay of clinical imaging with unlimited applications. However, a limitation of conventional contrast agents in MRI is the insufficient signal-to-noise ratios due to relaxivity. Gadobutrol (1.0 mmol/ml), an extracellular macrocyclic contrast agent of high stability, is indicated for contrast-enhanced MRI of adults, adolescents and children 2 years of age and older. Gadobutrol offers increased T 1 relaxivity, which improves MR image quality and clinical use of the technique.",
keywords = "CNS, contrast-enhanced MRA, contrast-enhanced MRI, Gadavist™, gadobutrol, gadolinium-based contrast agent, Gadovist™, kidney, liver",
author = "Gutierrez, {Juan E.} and Sara Koenig and Josy Breuer",
year = "2012",
month = "2",
doi = "10.2217/iim.11.70",
language = "English (US)",
volume = "4",
pages = "25--40",
journal = "Imaging in Medicine",
issn = "1755-5191",
publisher = "Future Medicine Ltd.",
number = "1",

}

TY - JOUR

T1 - Overview on the efficacy and safety of gadobutrol

T2 - An MRI contrast agent for the CNS, body and vessels

AU - Gutierrez, Juan E.

AU - Koenig, Sara

AU - Breuer, Josy

PY - 2012/2

Y1 - 2012/2

N2 - Contrast-enhanced MRI has become a mainstay of clinical imaging with unlimited applications. However, a limitation of conventional contrast agents in MRI is the insufficient signal-to-noise ratios due to relaxivity. Gadobutrol (1.0 mmol/ml), an extracellular macrocyclic contrast agent of high stability, is indicated for contrast-enhanced MRI of adults, adolescents and children 2 years of age and older. Gadobutrol offers increased T 1 relaxivity, which improves MR image quality and clinical use of the technique.

AB - Contrast-enhanced MRI has become a mainstay of clinical imaging with unlimited applications. However, a limitation of conventional contrast agents in MRI is the insufficient signal-to-noise ratios due to relaxivity. Gadobutrol (1.0 mmol/ml), an extracellular macrocyclic contrast agent of high stability, is indicated for contrast-enhanced MRI of adults, adolescents and children 2 years of age and older. Gadobutrol offers increased T 1 relaxivity, which improves MR image quality and clinical use of the technique.

KW - CNS

KW - contrast-enhanced MRA

KW - contrast-enhanced MRI

KW - Gadavist™

KW - gadobutrol

KW - gadolinium-based contrast agent

KW - Gadovist™

KW - kidney

KW - liver

UR - http://www.scopus.com/inward/record.url?scp=84857220437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857220437&partnerID=8YFLogxK

U2 - 10.2217/iim.11.70

DO - 10.2217/iim.11.70

M3 - Article

AN - SCOPUS:84857220437

VL - 4

SP - 25

EP - 40

JO - Imaging in Medicine

JF - Imaging in Medicine

SN - 1755-5191

IS - 1

ER -